Title
Guidelines on BFAD Product Brand Names
Law
Doh Administrative Order No. 2005-0016
Decision Date
Jun 21, 2005
The Department of Health establishes guidelines for the registration of brand names for food, drugs, and cosmetics, promoting the use of generic names while addressing intellectual property rights issues to ensure product safety and efficacy.
A

Purpose and Objective

  • To set general policies and guidelines on brand names for BFAD product registrations.
  • To promote generic/unbranded pharmaceutical products while recognizing the jurisdiction of BFAD, IPO, and courts.
  • BFAD’s role limited to ensuring product safety, efficacy, and quality, not marketing or promotion of brand names.

Scope and Coverage

  • Applies to all foods, cosmetics, drugs, devices, and household hazardous substances applying for:
    • Initial registration,
    • Brand name changes,
    • Inclusion of brand names in registered generic/unbranded pharmaceutical products with BFAD.

Definitions

  • Brand Name: Name given by manufacturers/traders/importers to distinguish products.
  • Certificate of Product Registration (CPR): License issued post-evaluation for marketing/distribution.
  • Certificate of Product Listing (CPL): Certificate for cosmetics qualified for listing without pre-market approval.
  • Generic Name: Scientifically recognized active ingredient names or official generics designated by BFAD.
  • Product Classification: Distinct categories such as food, cosmetic, drug, veterinary product, device, diagnostic reagents, and household hazardous substances.

General Guidelines on Brand Names

  • Generally, any name may be accepted as brand name for CPR/CPL application.
  • Strong encouragement for use of generic/unbranded names for pharmaceutical products per Generics Act.
  • Prohibition on brand names that:
    • Are identical to existing BFAD-registered names in the same product classification.
    • Are offensive, obscene, scandalous, or contrary to public morals and policy.
  • Brand name evaluation and acceptance occurs simultaneously with product registration processing.
  • Name change or inclusion for registered products must be evaluated within 30 days; absence of action deems acceptance.
  • BFAD acceptance does not confer intellectual property rights or endorse the brand name use.
  • Applicants must execute an affidavit undertaking to:
    • Change the brand name if legally prohibited from use.
    • Indemnify BFAD from third-party claims related to the brand name.

Procedures for Disputes

  • BFAD to notify complainants that intellectual property disputes fall under IPO or courts’ jurisdiction.
  • Notifications of alleged intellectual property claims shall not delay or suspend BFAD’s processing unless restrained by IPO or court orders.

Separability Clause

  • Invalid or unenforceable provisions of this Order do not affect the validity or enforceability of the remaining provisions.

Transitory and Repealing Clause

  • Applies to previously pending brand name clearance applications.
  • Repeals Administrative Order No. 76 (1984), Bureau Circular No. 21 (1999), Bureau Circular No. 08 (2003), and other inconsistent issuances.

Effectivity

  • The Order takes effect fifteen (15) days after publication in a newspaper of general circulation.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.